CLSN
Imunon, Inc.
1W: -6.7%
1M: -14.0%
3M: +2.1%
1Y: -86.3%
3Y: -91.7%
5Y: -91.7%
$1.95
Last traded 2022-09-20 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$14.5M
52W Range—
Volume56,809
Avg Volume60,967
Beta2.26
Dividend—
Analyst Ratings
Company Info
CEOMichael Tardugno
Employees29
SectorHealthcare
IndustryBiotechnology
IPO Date1993-10-27
Websitecelsion.com
997 Lenox Dr Ste 100
Lawrence Township, NJ 08648
US
Lawrence Township, NJ 08648
US
16098969100
About Imunon, Inc.
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Le Goff Corinne | A-Award | 177,000 | — | 2022-07-18 |
| Le Goff Corinne | 0 | — | 2022-07-18 | |
| Kardaras Constantine | A-Award | 1,750 | — | 2022-06-13 |
| Tumminello Timothy J | A-Award | 7,500 | — | 2022-06-13 |
| Chow Pok Yu Augustin | A-Award | 7,500 | — | 2022-06-13 |